BVS Q1 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$117M+43.4% YoY

Gross Profit

$76M64.5% margin

Operating Income

-$21M-18.3% margin

Net Income

-$11M-9.6% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-10.1%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$675M

Stockholders' Equity

$450M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$117M	$82M	+43.4%
Gross Profit	$76M	$60M	+27.1%
Operating Income	-$21M	$22M	-197.5%
Net Income	-$11M	$25M	-145.2%

Revenue Segments

Pain Treatments

$52M44%

Restorative Therapies

$34M29%

Surgical Solutions

$31M26%

Geographic Segments

UNITED STATES

$104M89%

Non-US

$13M11%